FONAR CORP

Listed Company

FONRCIK 0000355019NasdaqAcceleratedSmaller ReportingElectromedical & Electrotherapeutic ApparatusDelawareFY ends Jun 30

Period

FY 2025

Revenue

$104.35M

Net Income

$8.33M

Total Assets

$216.91M

Equity

$172.61M

Shares Out

6.36M

Op. Cash Flow

$11.26M

Business

FONAR Corporation designs, manufactures, sells and services magnetic resonance imaging (MRI) scanners and operates a physician management and diagnostic services business through its subsidiary, HMCA. Its principal products and services include the Upright® open MRI scanner, related software, upgrades and service contracts, plus HMCA’s administrative, billing, credentialing and facility operation services and ancillary imaging modalities. The company reports two segments: a medical equipment segment and a physician management/diagnostic services segment through HMCA, which owns and manages imaging centers. FONAR markets to private diagnostic imaging centers and hospital outpatient facilities, distributes through HMCA-managed outpatient centers and pursues foreign sales subject to regulatory approvals.

Summary from filing dated 2025-09-22

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Patient fee revenue net of contractual allowances and discounts	33	34	30	30	23
Product sales	563,296	737,727	731,607	517,939	1
Service and repair fees	8	7	7	8	8
Service and repair fees related parties	180,000	139,167	110,000	110,000	110,000
Management and other fees	50	49	49	48	47
Management and other fees related medical practices	12	12	12	12	11
Total Revenues Net	104	103	99	98	90
Costs related to product sales	1	1	852,025	416,814	1
Costs related to service and repair fees	5	4	3	3	3
Costs related to service and repair fees related parties	323,504	144,413	44,983	43,344	39,466
Costs related to patient fee revenue	19	18	16	13	11
Costs related to management and other fees	30	29	27	27	25
Costs related to management and other fees related medical practices	6	6	6	7	6
Research and development	2	2	2	1	2
Selling, general and administrative expenses	30	27	29	24	25
Total Costs and Expenses	93	86	84	76	73
Income from Operations	12	17	15	22	17
Interest expense	−25,611	−76,997	−50,131	—	—
Interest income related party	51,917	25,959	0	—	—
Investment income	2	2	1	247,158	311,931
Other income related party	0	576,857	0	—	—
Other income	36,195	78,763	−202,720	861,087	504,450
Income before Provision for Income Taxes and Noncontrolling Interests	14	19	16	23	18
Provision for Income Taxes	−3	−5	−4	−6	−4
Consolidated Net Income	11	14	—	—	—
Net Income Noncontrolling Interests	−2	−4	−3	−5	−3
Net Income Attributable to FONAR	8	11	9	12	10

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Cash and cash equivalents	56	56	51	—	—
Short-term investments	120,494	136,102	32,799	32,326	32,177
Accounts receivable net of allowances for credit losses of $264,212 and $166,049 at June 30, 2025 and 2024, respectively	5	4	4	—	—
Medical receivables	24	24	21	20	18
Management and other fees receivable net of allowances for credit losses of $14,295,988 and $12,369,921 at June 30, 2025 and 2024, respectively	43	42	36	—	—
Management and other fees receivable related party medical practices net of allowances for credit losses of $7,136,836 and $6,110,399 at June 30, 2025 and 2024, respectively	10	10	9	9	8
Inventories - net	3	3	3	—	—
Prepaid expenses and other current assets related party	410,659	—	—	—	—
Prepaid expenses and other current assets	2	1	2	1	1
Total Current Assets	145	140	126	119	109
Accounts receivable long term	4	829,473	710,085	2	3
Note receivable related party	554,857	581,183	0	—	—
Deferred income tax asset	6	7	10	13	16
Property and equipment net	19	19	22	22	22
Right-of-use-asset operating leases	35	38	33	34	30
Right-of-use-asset finance lease	376,569	530,348	729,229	928,109	1
Goodwill	4	4	4	4	4
Other intangible assets net	3	3	3	4	4
Other assets	475,680	481,147	523,506	526,269	666,514
Total Assets	217	214	201	199	190
Current portion of long-term debt	—	47,002	43,767	—	—
Accounts payable	1	2	2	2	2
Other current liabilities	7	8	5	6	9
Operating lease liabilities current portion	3	3	4	4	4
Finance lease liability current portion	244,237	225,786	217,597	210,140	202,741
Unearned revenue on service contracts	5	4	4	4	4
Customer deposits	354,244	443,471	602,377	361,245	731,101
Total Current Liabilities	17	18	16	17	20
Unearned revenue on service contracts	4	1	760,242	2	3
Deferred income tax liability	321,159	371,560	394,758	215,726	238,316
Due to related party medical practices	92,663	92,663	92,663	—	—
Operating lease liabilities net of current portion	35	37	32	33	29
Finance lease liability net of current portion	142,523	394,723	620,481	838,291	1
Long-term debt, less current portion	—	66,938	115,075	—	—
Other liabilities	172,853	32,026	41,750	106,541	171,331
Total Long-Term Liabilities	40	40	34	36	34
Total Liabilities	57	57	50	53	54
Paid-in capital in excess of par value	179	181	183	185	185
Accumulated deficit	−5	−14	−24	−34	−46
Treasury stock, at cost 34,840 and 45,081 shares of common stock at June 30, 2025 and 2024, respectively	−859,893	−1	−515,820	−675,390	−675,390
Total Fonar Corporations Stockholders Equity	173	166	158	150	138
Noncontrolling interests	−13	−9	−7	−4	−3
Total Equity	160	157	151	146	135
Total Liabilities and Equity	217	214	201	199	190

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Consolidated Net Income	11	14	—	—	—
Depreciation and amortization	5	5	5	—	—
Provision for credit losses	3	2	6	1	6
Deferred income tax - net	823,660	3	3	3	3
Net change in operating right-of-use assets and lease liabilities	−493	−229,590	—	—	—
Gain on sale of equipment related party	—	−581,183	—	—	—
Gain on disposition of fixed assets	—	−75,411	213,244	—	—
Abandoned patents	55,707	225,419	0	—	—
Accounts, medical and management fee receivable(s)	−9	−12	−8	−6	−12
Notes receivable	—	55,200	−64,532	—	—
Notes receivable related party	26,326	—	—	—	—
Inventories	−97,241	−145,775	−209,845	−696,402	−14,649
Prepaid expenses and other current assets	−1	266,606	−438,911	—	—
Other assets	5,467	42,359	2,763	129,411	−18,087
Accounts payable	−553,562	276,669	19,685	−314,766	−99,224
Other current liabilities	3	3	−3	−4	1
Customer advances	−89,227	−158,906	241,132	−369,856	−123,478
Finance lease liabilities	−79,970	−217,569	−210,353	—	—
Other liabilities	140,826	−9,724	−64,791	—	—
NET CASH PROVIDED BY OPERATING ACTIVITIES	11	14	14	15	19
Purchases of property and equipment	−4	−789,961	−4	−5	−4
Proceeds (Purchase) from short-term investment	15,608	−103,303	−473	−149	−293
Proceeds from sale of equipment	0	75,411	0	—	—
Cost of patents	−25,325	−32,885	−119,571	−87,882	−163,705
NET CASH USED IN INVESTING ACTIVITIES	−4	−850,738	−4	−5	−5
Repayment of borrowings and finance obligations	−113,940	−44,902	−36,615	−37,239	−103,335
Sale of noncontrolling interest	132,000	—	—	—	—
Purchase of treasury stock	−2	−3	−2	—	—
Distributions to noncontrolling interests	−6	−6	−6	−6	−7
NET CASH USED IN FINANCING ACTIVITIES	−7	−8	−8	−6	−7
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	−7,557	5	3	4	8

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro